Stephens reaffirmed their overweight rating on shares of PACS Group (NYSE:PACS - Free Report) in a report published on Tuesday morning, Benzinga reports. The firm currently has a $31.00 price objective on the stock.
PACS has been the topic of a number of other research reports. Truist Financial began coverage on PACS Group in a report on Monday, May 6th. They set a buy rating and a $32.00 target price on the stock. Royal Bank of Canada started coverage on PACS Group in a research note on Monday, May 6th. They set an outperform rating and a $30.00 price target on the stock. Oppenheimer started coverage on PACS Group in a research report on Monday, May 6th. They issued an outperform rating and a $31.00 target price on the stock. JPMorgan Chase & Co. started coverage on PACS Group in a research report on Monday, May 6th. They issued an overweight rating and a $27.00 target price on the stock. Finally, Citigroup started coverage on PACS Group in a research report on Monday, May 6th. They issued a buy rating and a $32.00 target price on the stock. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of Buy and a consensus price target of $30.50.
Get Our Latest Stock Analysis on PACS Group
PACS Group Stock Performance
Shares of PACS traded up $1.84 on Tuesday, reaching $26.92. The stock had a trading volume of 532,238 shares, compared to its average volume of 584,310. PACS Group has a twelve month low of $22.61 and a twelve month high of $27.22.
Insider Buying and Selling at PACS Group
In other PACS Group news, CEO Jason Hulse Murray sold 1,607,142 shares of the firm's stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $21.00, for a total value of $33,749,982.00. Following the transaction, the chief executive officer now directly owns 62,754,551 shares of the company's stock, valued at $1,317,845,571. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
About PACS Group
(
Get Free Report)
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
See Also
Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
